Líliam Oliveira
Director of Formulation & Process Development Providence Therapeutics
Seminars
Thursday 1st October 2026
Optimizing RNA-LNP Process Development & CMC Strategies to Enable Robust, Scalable Manufacturing of Vaccines
5:00 pm
- Exploring key considerations in RNA-LNP process development to improve reproducibility, product quality, and manufacturing robustness across development stages
- Sharing approaches to balancing formulation, process parameters, and analytical insight to reduce variability and support efficient scale-up
- Discussing how integrated CMC strategies can de-risk tech transfer, strengthen process understanding, and accelerate progression from early development to clinical and commercial manufacturing
